Latest videos


Colorectal cancer affects nearly 6 in 100 people. The best protection for those at average risk for the disease is screening colonoscopies. Men and women at average risk for colorectal cancer should begin colorectal cancer screening beginning at age 50. African American men and women should begin screening exams at age 45. You can also reduce your risk for the disease over a lifetime by maintaining a healthy diet with modest fat, high fiber, and a healthy lifestyle with high activity.
Learn more about colorectal screenings https://www.mdanderson.org/pre....vention-screening/ge
Learn more about colorectal cancer https://www.mdanderson.org/can....cer-types/colon-canc
Request an appointment at MD Anderson by calling 1-877-632-6789 or online: https://my.mdanderson.org/requestappointment


Mariana Gantus-Wall was 37 years old when she found out she had colon cancer. She was young and pregnant. She delivered her baby, but sadly, she passed away one year after being diagnosed. March is National Colon Cancer Awareness Month. A new report says colon cancer is on the rise among young adults 20-49. Meet the survivors who have been impacted by colon cancer, as well as what symptoms to look out for. https://abc7ne.ws/3lKBw1R
#coloncancer #cancer #health #abc7news


What are the signs and symptoms of colon and rectal cancer? Dana-Farber's Jeffrey Meyerhardt, MD talks about symptoms, screening, and what you can do to prevent colon and rectal cancer. Learn more about the Colon and Rectal Cancer Center at Dana-Farber Cancer Institute: http://www.dana-farber.org/col....on-and-rectal-cancer


In 2015 Ron was diagnosed with stage 4 colorectal cancer. He received traditional, but debilitating, chemotherapy treatment for 9 months. #CIM18 #PatientStories
He wasn’t able to eat or sleep, and his devastated wife, Maria, searched for other options. In 2016, after learning he carried a genetic mutation linked to Lynch syndrome, Ron began a nivolumab/ipilimumab combination immunotherapy on a clinical trial at the University of Pittsburgh Medical Center. Today, Ron continues to receive nivo/ipi as part of routine care and, for the past 2 years, has had no evidence of disease progression. “I am able to live on immunotherapy,” Ron explained. http://www.cancerresearch.org/patients
This video is presented as part of the Cancer Research Institute 6th Annual Cancer Immunotherapy Month awareness campaign this June 2018. Learn more about cancer immunotherapy and its potential to save more lives at http://www.cancerresearch.org/june.
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org
**
Ron passed away in December 2018. His family feels grateful for the additional time and quality of life that immunotherapy provided Ron, and hope that someday immunotherapy is considered first-line therapy for more types of cancer.”